Diagnostic Products And Minerva Sign Development Agreement

Diagnostic Products Corp. and Minerva Pharmaceuticals Inc. have entered into a license agreement for the development of immunoassays for a newly described malignancy protein. Minerva Pharmaceuticals is a privately held Baltimore-based company formed for the purpose of commercialising platform technology licensed from the University of Maryland. Minerva founding scientists discovered that altered components of the Read more about Diagnostic Products And Minerva Sign Development Agreement[…]

Diagnostic Products Announces License Agreement With MBL

Diagnostic Products Corporation (DPC) has announced that MBL of Japan has granted DPC a license to develop and commercialize diagnostic antinuclear antibody (ANA) assays on its IMMULITE immunochemistry analyzers, and applications for the DPC ANA lineBlot assay. “The combination of IMMULITE automation and the ANA technology represents a significant step forward in autoimmune testing,” said Read more about Diagnostic Products Announces License Agreement With MBL[…]